Buay, Reymark S.
HRN: 15-76-08 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/12/2025
12/19/2025
IV
700mg
Q6hours
PCAP-B
Checking Final Appropriateness